Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 11, 2010, Pages 2436-2442

  Baglin, T ^a   Douketis, J ^b   Tosetto, A ^c   Marcucci, M ^d   Cushman, M ^e   Kyrle, P ^f   Palareti, G ^g   Poli, D ^h   Tait, R C ⁱ   Iorio, A ^d  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

^c SAN BORTOLO HOSPITAL   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h CAREGGI UNIVERSITY HOSPITAL   (Italy)

ⁱ GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Disease recurrence; Epidemiology; Prognosis; Risk factors; Venous thrombosis

Indexed keywords

ANTICOAGULATION; ARTICLE; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; COHORT STUDIES; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MUSCLE, SKELETAL; PHENOTYPE; PROPORTIONAL HAZARDS MODELS; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 78149277246     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.04022.x     Document Type: Article

References (23)

1. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279: 458-62.
2. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999; 159: 445-53.
3. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861-6.
4. Laporte S, Mismetti P, Decousus H, Uresandi F, Otero R, Lobo JL, Monreal M. Clinical predictors for fatal pulmonary embolism in 15, 520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117: 1711-6.
5. Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002; 88: 407-14.
6. Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, Nony P, Sanson C, Boissel JP. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001; 103: 2453-60.
7. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H. A comparison of 6 weeks with 6 months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 1995; 332: 1661-5.
8. Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T, Poli D, Lim W. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 2008; 149: 481-90. W94.
9. Iorio A, Douketis JD, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Tosetto A. D-dimer to predict thrombosis recurrence after unprovoked venous thromboembolism: effect of patient- and D-dimer-related factors on recurrence prediction. J Thromb Haemost 2009; 7: OC-TH-002.
10. Altman DG. Systematic reviews of evaluations of prognostic variables. Br Med J 2001; 323: 224-8.
11. Merlin T, Weston A, Tooher R. Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'. BMC Med Res Methodol 2009; 9: 34.
12. Palareti G, Legnani C, Cosmi B, Valdre L, Lunghi B, Bernardi F, Coccheri S. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 2003; 108: 313-8.
13. Tait RC, Lowe G, McColl MD, McMahon A, Robertson I, King CR, Clarke S, Conkie J, Roditi GH, Walker ID. Predicting risk of recurrent venous thrombosis using a 5-point scoring sysytem including fibrin D-dimer. J Thromb Haemost 2007; 5(Suppl. 2): 60.
14. Baglin T, Palmer C, Luddington R, Baglin C. Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors. J Thromb Haemost 2008; 6: 577-82.
15. Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Weltermann A, Wagner O, Kyrle PA. D-dimer levels and risk of recurrent venous thromboembolism. JAMA 2003; 290: 1071-4.
16. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006; 355: 1780-9.
17. Poli D, Antonucci E, Ciuti G, Abbate R, Prisco D. Combination of D-dimer, F1 + 2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal. J Thromb Haemost 2008; 6: 708-10.
18. Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost 2006; 4: 1208-14.
19. American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease. Chest 2008; 133: 454S-545S.
20. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-64.
21. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107(23 Suppl. 1): I22-30.
22. Turkstra F, Karemaker R, Kuijer PM, Prins MH, Buller HR. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Thromb Haemost 1999; 81: 345-8.
23. Monreal M, Lafoz E, Ruiz J, Callejas JM, Arias A. Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: a prospective study. Eur J Vasc Surg 1994; 8: 584-9.